{"nct_id":"NCT04392648","title":"A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)","status":"WITHDRAWN","status_verified_date":"2020-07","start_date":"2020-06-24","start_date_type":"ESTIMATED","primary_completion_date":"2023-11-10","primary_completion_date_type":"ESTIMATED","completion_date":"2023-11-10","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["TAK"]}